Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Select Medical Holdings (SEM) Enterprise Value (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Enterprise Value for 9 consecutive years, with -$4.7 million as the latest value for Q1 2026.

  • For Q1 2026, Enterprise Value fell 101.78% year-over-year to -$4.7 million; the TTM value through Mar 2026 reached -$4.7 million, down 101.78%, while the annual FY2025 figure was $284.8 million, 15.84% up from the prior year.
  • Enterprise Value hit -$4.7 million in Q1 2026 for Select Medical Holdings, down from $284.8 million in the prior quarter.
  • Across five years, Enterprise Value topped out at $284.8 million in Q4 2025 and bottomed at -$161.0 million in Q3 2024.
  • Average Enterprise Value over 5 years is -$17.2 million, with a median of -$74.7 million recorded in 2022.
  • Year-over-year, Enterprise Value crashed 293.23% in 2022 and then surged 347.13% in 2025.
  • Select Medical Holdings' Enterprise Value stood at -$138.7 million in 2022, then soared by 206.56% to $147.8 million in 2023, then soared by 66.34% to $245.9 million in 2024, then rose by 15.84% to $284.8 million in 2025, then tumbled by 101.66% to -$4.7 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$4.7 million, $284.8 million, and -$51.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.